InsiderTrades.com logo
Did You See Trump’s Bombshell Exec. Order 001?
From Banyan Hill Publishing   |   Ad
Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...
I put all the details together for you here — but please hurry. 

POLB Insider Trading

Insider Ownership Percentage: 24.71%
Insider Buying (Last 12 Months): £116,624.04
Insider Selling (Last 12 Months): GBX 0

Poolbeg Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Poolbeg Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Poolbeg Pharma Share Price & Price History

Current Price: GBX 7.35
Price Change: +0.30 (1.20%)
As of 12/13/2024 07:57 AM ET

This chart shows the closing price history over time for POLB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The #1 Crypto for AI
From Weiss Ratings   |   Ad
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”
Learn more about it by watching THIS NOW.

Poolbeg Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/21/2024Jeremy SkillingtonInsiderBuy154,764GBX 11£17,024.04
2/19/2024Cathal FrielInsiderBuy830,000GBX 12£99,600
10/5/2022Jeremy SkillingtonInsiderBuy718,733GBX 5£35,936.65
See Full Table
The #1 Crypto for AI
From Weiss Ratings   |   Ad
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”
Learn more about it by watching THIS NOW.

SEC Filings (Institutional Ownership Changes) for Poolbeg Pharma (LON:POLB)

1.23% of Poolbeg Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Poolbeg Pharma logo
Poolbeg Pharma plc operates as a biopharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an in­licensed first­in­class broad spectrum RNA­based immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro­ and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.
Read More on Poolbeg Pharma

Today's Range

Now: GBX 7.35
Low: 7.10
High: 7.60

50 Day Range

MA: GBX 7.90
Low: 7.10
High: 9.10

52 Week Range

Now: GBX 7.35
Low: 6.96
High: 15.77

Volume

278,274 shs

Average Volume

1,655,929 shs

Market Capitalization

£36.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.11

Who are the company insiders with the largest holdings of Poolbeg Pharma?

Poolbeg Pharma's top insider shareholders include:
  1. Cathal Friel (Insider)
  2. Jeremy Skillington (Insider)
Learn More about top insider investors at Poolbeg Pharma.
Did You See Trump’s Bombshell Exec. Order 001?
From Banyan Hill Publishing   |   Ad
Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...
I put all the details together for you here — but please hurry.